(Q44168354)

30 November 2017

Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine (English)

1 reference

Japanese encephalitis virus

30 November 2017

0 references

phase I clinical trial

0 references

Japanese encephalitis

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00506-1

24 March 2024

author name string

Syoji Kuzuhara

1

1 reference

30 November 2017

Hideki Nakamura

2

1 reference

30 November 2017

Kenshi Hayashida

3

1 reference

30 November 2017

Junko Obata

4

1 reference

30 November 2017

Motoharu Abe

5

1 reference

30 November 2017

Kengo Sonoda

6

1 reference

30 November 2017

Kiyoto Nishiyama

7

1 reference

30 November 2017

Keishin Sugawara

8

1 reference

30 November 2017

Kengo Takeda

9

1 reference

30 November 2017

Tomitaka Honda

10

1 reference

30 November 2017

Hajime Matsui

11

1 reference

30 November 2017

Takamichi Shigaki

12

1 reference

30 November 2017

Yoichiro Kino

13

1 reference

30 November 2017

Hiroshi Mizokami

14

1 reference

30 November 2017

Masahiko Tanaka

15

1 reference

30 November 2017

Kyosuke Mizuno

16

1 reference

30 November 2017

Kohji Ueda

17

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

30 November 2017

7 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14575762

full work available at URL

24 March 2024

https://api.elsevier.com/content/article/PII:S0264410X03005061?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00506-1

https://api.elsevier.com/content/article/PII:S0264410X03005061?httpAccept=text/plain

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00506-1

24 March 2024

1 reference

30 November 2017

21

1 reference

30 November 2017

31

1 reference

30 November 2017

4519-4526

1 reference

Development of Vero cell-derived inactivated Japanese encephalitis vaccine

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900506-1

7 January 2021

Establishment of an analyzing method for a Japanese encephalitis virus neutralization test in Vero cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900506-1

7 January 2021

WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (Requirements for biological susbstances no. 50).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900506-1

7 January 2021

Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900506-1

7 January 2021

Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900506-1

7 January 2021

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900506-1

7 January 2021

Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900506-1

7 January 2021

Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900506-1

7 January 2021

Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900506-1

7 January 2021

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900506-1

7 January 2021

Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties

12

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00506-1

Production of purified Japanese encephalitis vaccine from Vero cells with roller bottles

24 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00506-1

24 March 2024

Identifiers

1 reference

release_nudn4tchlrb6xc3lpzypd2qdsi

30 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nudn4tchlrb6xc3lpzypd2qdsi

24 November 2022

mapped directly with Wikidata item

1 reference